Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Cohort Studies [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
cataract, age-related cortical [NCBI] 0.00233709
IS1 [NCBI] 0.00217346
SLI2 [NCBI] 0.00155659
systemic lupus erythematosus, susceptibility to, 8 [NCBI] 0.00155659
SLI1 [NCBI] 0.00155659
RA [NCBI] 0.00148423
SLE [NCBI] 0.0013985
systemic lupus erythematosus, susceptibility to, 7 [NCBI] 0.00119455
pelvic organ prolapse [NCBI] 0.00119455
IBD5 [NCBI] 0.00113
PSORS2 [NCBI] 0.00107537
HBFQTL3 [NCBI] 0.00103271
psoriasis susceptibility 8 [NCBI] 0.00103271
KLK3 [NCBI] 0.000904492
systemic lupus erythematosus, susceptibility to, 6 [NCBI] 0.000839059
carotid intimal medial thickness 2 [NCBI] 0.000777568
plasmodium falciparum fever episodes quantitative trait locus 1 [NCBI] 0.000777568
migraine with or without aura, susceptibility to, 8 [NCBI] 0.000777568
SPAX3 [NCBI] 0.000777568
BMND6 [NCBI] 0.000777568
BMND7 [NCBI] 0.000777568
cluster headache, familial [NCBI] 0.00077178
acne inversa, familial [NCBI] 0.000515653
testicular germ cell tumor 1 [NCBI] 0.000515653
attention deficit-hyperactivity disorder, susceptibility to, 2 [NCBI] 0.000515653
psoriasis susceptibility 6 [NCBI] 0.000515653
APOE [NCBI] 0.000495983
human immunodeficiency virus type 1, susceptibility to [NCBI] 0.000467926
AD [NCBI] 0.00044622
body mass index quantitative trait locus on chromosome 6 [NCBI] 0.00041885
AUTS7 [NCBI] 0.00041885
body mass index quantitative trait locus on chromosome 11 [NCBI] 0.00041885
stature quantitative trait locus 5 [NCBI] 0.00041885
GLC1M [NCBI] 0.00041885
ATFB1 [NCBI] 0.00041885
chiari malformation type i [NCBI] 0.000371779
PN [NCBI] 0.000357145
DYT6 [NCBI] 0.000357145
RP6 [NCBI] 0.000357145
pulmonary function [NCBI] 0.000357145
hypertension, essential, susceptibility to, 1 [NCBI] 0.000357145
RP24 [NCBI] 0.000357145
CORD8 [NCBI] 0.000357145
CORD5 [NCBI] 0.000357145
eosinophilia, familial [NCBI] 0.000357145
CRC [NCBI] 0.000348588
diabetes mellitus, transient neonatal, 1 [NCBI] 0.000325494
EGF [NCBI] 0.000322355
CELIAC2 [NCBI] 0.000312109
CORD7 [NCBI] 0.000312109
IBD3 [NCBI] 0.000312109
HBFQTL2 [NCBI] 0.000286409
stature as a quantitative trait [NCBI] 0.00027689
PD [NCBI] 0.000272183
diabetes mellitus, insulin-dependent, 2 [NCBI] 0.000263521
BMND3 [NCBI] 0.000248159
inclusion body myositis [NCBI] 0.000248159
MENOQ1 [NCBI] 0.000248159
MNG1 [NCBI] 0.000248159
APC [NCBI] 0.000243902
hemophagocytic lymphohistiocytosis, familial, 1 [NCBI] 0.000214931
IGES [NCBI] 0.000203367
IBD2 [NCBI] 0.000203367
centralopathic epilepsy [NCBI] 0.000185371
PARK3 [NCBI] 0.000185371
NGFB [NCBI] 0.000176123
carotid intimal medial thickness 1 [NCBI] 0.000175743
FA [NCBI] 0.000173422
apnea, obstructive sleep [NCBI] 0.000172429
pygmy [NCBI] 0.000169514
sjogren syndrome [NCBI] 0.000169514
AUTS6 [NCBI] 0.000169514
SHBG [NCBI] 0.00016245
telomere length, mean leukocyte [NCBI] 0.000155404
JBTS4 [NCBI] 0.000146848
obesity [NCBI] 0.000133309
MDD [NCBI] 0.000132816
MBL2 [NCBI] 0.000132144
MYP2 [NCBI] 0.000131325
leber optic atrophy, susceptibility to [NCBI] 0.000131325
CJD [NCBI] 0.000126929
MAFD6 [NCBI] 0.000125778
lymphoma, non-hodgkin, familial [NCBI] 0.000123433
twinning, dizygotic [NCBI] 0.000120955
VDR [NCBI] 0.000120825
AVP [NCBI] 0.000113529
NPY [NCBI] 0.000113256
CCR5 [NCBI] 0.000109404
MG [NCBI] 0.000109365
DTGA1 [NCBI] 0.000109111
ALD [NCBI] 0.000108158
VRNI [NCBI] 0.000107565
BBS [NCBI] 0.00010575
GFAP [NCBI] 0.000102367
panencephalitis, subacute sclerosing [NCBI] 9.85344e-05
LPL [NCBI] 9.83716e-05
TH [NCBI] 9.77965e-05
abdominal obesity-metabolic syndrome [NCBI] 9.48915e-05
ATD1 [NCBI] 9.48915e-05
thrombocytopenic purpura, autoimmune [NCBI] 9.30907e-05
IBD1 [NCBI] 9.09015e-05
LDS [NCBI] 8.47838e-05
RP [NCBI] 8.41553e-05
ARMD1 [NCBI] 8.28465e-05
osteoarthritis [NCBI] 8.15213e-05
ACHE [NCBI] 7.57327e-05
scleroderma, familial progressive [NCBI] 7.4543e-05
MC4R [NCBI] 7.34932e-05
SYNS2 [NCBI] 7.34188e-05
SCDO2 [NCBI] 7.34188e-05
KAL3 [NCBI] 7.34188e-05
hyperparathyroidism, primary, caused by water clear cell hyperplasia [NCBI] 7.34188e-05
leukocyte nuclear appendages, hereditary prevalence of [NCBI] 7.34188e-05
qt interval, variation in [NCBI] 7.34188e-05
KAL4 [NCBI] 7.34188e-05
aortic aneurysm, familial thoracic 5 [NCBI] 7.34188e-05
CMT4J [NCBI] 7.34188e-05
TCF7L2 [NCBI] 7.21602e-05
AS [NCBI] 6.98947e-05
ACE [NCBI] 6.936e-05
longevity [NCBI] 6.8843e-05
diaphragmatic hernia, congenital [NCBI] 6.874e-05
CCK [NCBI] 6.83165e-05
asthma, susceptibility to [NCBI] 6.62466e-05
body mass index [NCBI] 6.55426e-05
endometrial cancer [NCBI] 6.55426e-05
MJD [NCBI] 6.49918e-05
temporal arteritis [NCBI] 6.39915e-05
autism [NCBI] 6.36275e-05
AT [NCBI] 6.12617e-05
psoriatic arthritis, susceptibility to [NCBI] 5.98355e-05
COH1 [NCBI] 5.69463e-05
TNFRSF11B [NCBI] 5.61782e-05
PWS [NCBI] 5.55511e-05
aspirin resistance [NCBI] 5.49722e-05
tobacco addiction, susceptibility to [NCBI] 5.49722e-05
CRH [NCBI] 5.18832e-05
INSIG2 [NCBI] 5.1371e-05
BL [NCBI] 5.08555e-05
GBD1 [NCBI] 5.07501e-05
UBQLN1 [NCBI] 4.96109e-05
IRF5 [NCBI] 4.96109e-05
WAS [NCBI] 4.94804e-05
KCNJ11 [NCBI] 4.85908e-05
HLA-C [NCBI] 4.65606e-05
HCRTR2 [NCBI] 4.65606e-05
WFS2 [NCBI] 4.61646e-05
ARMD3 [NCBI] 4.61646e-05
AGS2 [NCBI] 4.61646e-05
SIDDT [NCBI] 4.61646e-05
SCDO3 [NCBI] 4.61646e-05
ASD2 [NCBI] 4.61646e-05
CMT2K [NCBI] 4.61646e-05
TSD [NCBI] 4.54306e-05
danubian endemic familial nephropathy [NCBI] 4.5263e-05
aortic valve disease [NCBI] 4.45881e-05
PLEKHA1 [NCBI] 4.31802e-05
NOD2 [NCBI] 4.26983e-05
CAT [NCBI] 4.26726e-05
LRRK2 [NCBI] 4.21448e-05
PPARG [NCBI] 4.16386e-05
DMD [NCBI] 4.0917e-05
APOB [NCBI] 4.00454e-05
TSC1 [NCBI] 3.85732e-05
holoprosencephaly [NCBI] 3.79968e-05
palatopharyngeal incompetence [NCBI] 3.79968e-05
BRCA2 [NCBI] 3.74711e-05
NPPA [NCBI] 3.71173e-05
BBS1 [NCBI] 3.70339e-05
DLG5 [NCBI] 3.70339e-05
COH1 [NCBI] 3.70339e-05
PCD [NCBI] 3.68103e-05
CELIAC3 [NCBI] 3.62012e-05
diaphragmatic hernia 3 [NCBI] 3.62012e-05
phace association [NCBI] 3.62012e-05
PEE4 [NCBI] 3.62012e-05
ARMD10 [NCBI] 3.62012e-05
charcot-marie-tooth disease, axonal, type 2i [NCBI] 3.62012e-05
cataract, age-related nuclear [NCBI] 3.62012e-05
brugada syndrome 2 [NCBI] 3.62012e-05
insulin-like growth factor i, resistance to [NCBI] 3.62012e-05
diabetic nephropathy, susceptibility to [NCBI] 3.62012e-05
PJS [NCBI] 3.52891e-05
MSH2 [NCBI] 3.51492e-05
FTO [NCBI] 3.48796e-05
PSORS1 [NCBI] 3.46356e-05
IGF2 [NCBI] 3.40042e-05
pseudoxanthoma elasticum, forme fruste [NCBI] 3.33458e-05
MBP [NCBI] 3.31987e-05
EVA [NCBI] 3.3098e-05
SPS [NCBI] 3.16488e-05
MKKS [NCBI] 3.15118e-05
acromegaly [NCBI] 3.12758e-05
DHRD [NCBI] 3.12758e-05
MEFV [NCBI] 3.07847e-05
vitamin d-dependent rickets, type ii [NCBI] 3.0545e-05
CD [NCBI] 3.03403e-05
HLA-B [NCBI] 3.02664e-05
DRPLA [NCBI] 3.01993e-05
AIP [NCBI] 3.01436e-05
CLDN16 [NCBI] 3.01436e-05
TG [NCBI] 2.9931e-05
CELIAC4 [NCBI] 2.99132e-05
IGAD2 [NCBI] 2.99132e-05
asthma-related traits, susceptibility to, 2 [NCBI] 2.99132e-05
trigonocephaly, nonsyndromic [NCBI] 2.99132e-05
heterotaxy, visceral, 2, autosomal [NCBI] 2.99132e-05
FHL4 [NCBI] 2.99132e-05
pars planitis [NCBI] 2.99132e-05
RASEF [NCBI] 2.9796e-05
C9ORF64 [NCBI] 2.9796e-05
C9ORF103 [NCBI] 2.9796e-05
CISD2 [NCBI] 2.9796e-05
BBS10 [NCBI] 2.9796e-05
C10ORF26 [NCBI] 2.9796e-05
IL10 [NCBI] 2.97075e-05
nijmegen breakage syndrome [NCBI] 2.9346e-05
FMO3 [NCBI] 2.92794e-05
prostate cancer [NCBI] 2.83829e-05
HD [NCBI] 2.81563e-05
loc387715 gene [NCBI] 2.78274e-05
MTTL1 [NCBI] 2.74846e-05
ADRB2 [NCBI] 2.74798e-05
CHAT [NCBI] 2.73424e-05
CF [NCBI] 2.69263e-05
KRT8 [NCBI] 2.68293e-05
PCNA [NCBI] 2.68245e-05
SMAX1 [NCBI] 2.63882e-05
kabuki syndrome [NCBI] 2.61272e-05
stroke, ischemic [NCBI] 2.5941e-05
CEP290 [NCBI] 2.59147e-05
CTLA4 [NCBI] 2.58741e-05
peroxisomal acyl-coa oxidase deficiency [NCBI] 2.53708e-05
mental retardation, x-linked, with cerebellar hypoplasia and distinctive facial appearance [NCBI] 2.53708e-05
KRS [NCBI] 2.53708e-05
asthma-related traits, susceptibility to, 5 [NCBI] 2.53708e-05
COMT [NCBI] 2.51718e-05
GTS [NCBI] 2.51421e-05
TNFSF6 [NCBI] 2.4909e-05
ETM1 [NCBI] 2.44035e-05
PKHD1 [NCBI] 2.42888e-05
MPZ [NCBI] 2.3944e-05
GIST [NCBI] 2.38639e-05
SCARB1 [NCBI] 2.35596e-05
THBD [NCBI] 2.35596e-05
hypogonadotropic hypogonadism [NCBI] 2.28837e-05
KCNQ1OT1 [NCBI] 2.28773e-05
DLL3 [NCBI] 2.28773e-05
ALB [NCBI] 2.25515e-05
SCN5A [NCBI] 2.24997e-05
TLR4 [NCBI] 2.24111e-05
TGFBR1 [NCBI] 2.22363e-05
stickler syndrome, type i, nonsyndromic ocular [NCBI] 2.18565e-05
l-2-hydroxyglutaric aciduria [NCBI] 2.18565e-05
noonan-like/multiple giant cell lesion syndrome [NCBI] 2.18565e-05
PPNAD1 [NCBI] 2.18565e-05
CGL1 [NCBI] 2.18565e-05
charcot-marie-tooth disease and deafness [NCBI] 2.18565e-05
CINCA [NCBI] 2.18565e-05
glaucoma, normal tension, susceptibility to [NCBI] 2.18565e-05
LGMD2F [NCBI] 2.18565e-05
HDL1 [NCBI] 2.18565e-05
oeis complex [NCBI] 2.18565e-05
HOA [NCBI] 2.18565e-05
IRDN [NCBI] 2.16321e-05
MUTYH [NCBI] 2.16321e-05
SGCE [NCBI] 2.16321e-05
hodgkin lymphoma [NCBI] 2.16207e-05
sudden infant death syndrome [NCBI] 2.16207e-05
MADD [NCBI] 2.16207e-05
GKAP1 [NCBI] 2.15883e-05
CCDC28B [NCBI] 2.15883e-05
mesoderm posterior 1 [NCBI] 2.15883e-05
kiaa0274 [NCBI] 2.15883e-05
g-substrate [NCBI] 2.15883e-05
TTC8 [NCBI] 2.15883e-05
GDNF [NCBI] 2.15526e-05
BRCA1 [NCBI] 2.15476e-05
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase [NCBI] 2.10611e-05
PRL [NCBI] 2.09486e-05
RPGR [NCBI] 2.08068e-05
SSTR2 [NCBI] 2.052e-05
BCNS [NCBI] 2.05168e-05
SCA6 [NCBI] 2.04337e-05
LWD [NCBI] 2.04337e-05
SCDO1 [NCBI] 2.0358e-05
HLA-DQB1 [NCBI] 2.00059e-05
DBH [NCBI] 2.00059e-05
GATA4 [NCBI] 2.00059e-05
FSHMD1A [NCBI] 1.96821e-05
ABCC8 [NCBI] 1.96504e-05
CYP19A1 [NCBI] 1.95419e-05
lynch syndrome i [NCBI] 1.95399e-05
WFS1 [NCBI] 1.95165e-05
CASP8 [NCBI] 1.95165e-05
behcet syndrome [NCBI] 1.91834e-05
PPR [NCBI] 1.91834e-05
PINK1 [NCBI] 1.90496e-05
CORD3 [NCBI] 1.90215e-05
CPVT [NCBI] 1.90215e-05
FHL2 [NCBI] 1.90215e-05
ARMD7 [NCBI] 1.90215e-05
CFH [NCBI] 1.90097e-05
PKD1 [NCBI] 1.88536e-05
TGFB1 [NCBI] 1.88374e-05
HFE [NCBI] 1.87011e-05
GCCR [NCBI] 1.86108e-05
CRP [NCBI] 1.86035e-05
HLA-DRB1 [NCBI] 1.86035e-05
ATP13A2 [NCBI] 1.85152e-05
IGF2BP3 [NCBI] 1.85152e-05
STOX1 [NCBI] 1.85152e-05
THRAP2 [NCBI] 1.85152e-05
MTTQ [NCBI] 1.85152e-05
CUL5 [NCBI] 1.85152e-05
kinesin family member 27, kif27 [NCBI] 1.85152e-05
SLC22A18AS [NCBI] 1.85152e-05
NOS1AP [NCBI] 1.85152e-05
KSS [NCBI] 1.83993e-05
SCN1A [NCBI] 1.81764e-05
HBB [NCBI] 1.81662e-05
NF1 [NCBI] 1.80577e-05
DYX1 [NCBI] 1.80543e-05
DRD4 [NCBI] 1.75344e-05
TSC2 [NCBI] 1.75344e-05
DGS [NCBI] 1.7518e-05
AMH [NCBI] 1.75061e-05
PTH [NCBI] 1.74532e-05
PCOS1 [NCBI] 1.71857e-05
DHFR [NCBI] 1.70602e-05
TFF1 [NCBI] 1.69961e-05
FABP2 [NCBI] 1.69961e-05
CPI [NCBI] 1.67819e-05
PARK2 [NCBI] 1.67351e-05
PARK7 [NCBI] 1.66694e-05
colorectal adenomatous polyposis, autosomal recessive [NCBI] 1.66694e-05
PGL4 [NCBI] 1.66694e-05
SLEB1 [NCBI] 1.66694e-05
ODG2 [NCBI] 1.66694e-05
IDD [NCBI] 1.66694e-05
JBTS3 [NCBI] 1.66694e-05
UNC13D [NCBI] 1.65334e-05
CD72 [NCBI] 1.65334e-05
PRKCH [NCBI] 1.65334e-05
TSNAX [NCBI] 1.65334e-05
RMI1 [NCBI] 1.65334e-05
PROKR2 [NCBI] 1.65334e-05
MUC7 [NCBI] 1.65334e-05
TLE4 [NCBI] 1.65334e-05
SLC28A3 [NCBI] 1.65334e-05
BBS2 [NCBI] 1.65334e-05
HOXD4 [NCBI] 1.65334e-05
USH1G [NCBI] 1.65334e-05
GPD1L [NCBI] 1.65334e-05
WWC1 [NCBI] 1.65334e-05
SLC12A1 [NCBI] 1.65334e-05
IL1B [NCBI] 1.6282e-05
PRODH [NCBI] 1.6282e-05
SMS [NCBI] 1.59969e-05
PTPN11 [NCBI] 1.59439e-05
IL1A [NCBI] 1.59439e-05
HP [NCBI] 1.57136e-05
TF [NCBI] 1.56393e-05
MAOB [NCBI] 1.56175e-05
PON1 [NCBI] 1.54128e-05
polycystic kidneys [NCBI] 1.53443e-05
SAA1 [NCBI] 1.53021e-05
EFEMP1 [NCBI] 1.50701e-05
CXCR6 [NCBI] 1.50701e-05
GDF9 [NCBI] 1.50701e-05
GPR74 [NCBI] 1.50701e-05
PLXNA2 [NCBI] 1.50701e-05
g30 gene [NCBI] 1.50701e-05
TCF7 [NCBI] 1.50701e-05
IRAK3 [NCBI] 1.50701e-05
PPOX [NCBI] 1.49969e-05
ABCB1 [NCBI] 1.49332e-05
ICAM1 [NCBI] 1.47015e-05
NIDDM1 [NCBI] 1.46783e-05
fundus albipunctatus [NCBI] 1.46783e-05
SYNS1 [NCBI] 1.46783e-05
SLOS [NCBI] 1.4423e-05
WBS [NCBI] 1.4423e-05
PAI1 [NCBI] 1.44153e-05
ABCC6 [NCBI] 1.44153e-05
FRDA [NCBI] 1.43307e-05
homocysteinemia [NCBI] 1.4183e-05
ASPA [NCBI] 1.41377e-05
LBP [NCBI] 1.41367e-05
CLEC16A [NCBI] 1.3912e-05
KIR2DL3 [NCBI] 1.3912e-05
ITIH4 [NCBI] 1.3912e-05
CTNND1 [NCBI] 1.3912e-05
HOXB2 [NCBI] 1.3912e-05
PROK2 [NCBI] 1.3912e-05
TLE1 [NCBI] 1.3912e-05
PLA2G1B [NCBI] 1.3912e-05
HSN2 [NCBI] 1.3912e-05
MESP2 [NCBI] 1.3912e-05
P2RX4 [NCBI] 1.3912e-05
EHD1 [NCBI] 1.3912e-05
STX11 [NCBI] 1.3912e-05
regulatory associated protein of mtor [NCBI] 1.3912e-05
CHRNB4 [NCBI] 1.3912e-05
SRI [NCBI] 1.3912e-05
CFC1 [NCBI] 1.3912e-05
g72 gene [NCBI] 1.3912e-05
KCNE2 [NCBI] 1.3912e-05
CAMTA1 [NCBI] 1.3912e-05
ALG6 [NCBI] 1.3912e-05
HNRNPK [NCBI] 1.3912e-05
HSPA1L [NCBI] 1.3912e-05
JAG1 [NCBI] 1.38684e-05
MS [NCBI] 1.37854e-05
FRAP1 [NCBI] 1.36781e-05
PEE1 [NCBI] 1.3615e-05
PXE [NCBI] 1.36041e-05
ACADM [NCBI] 1.34855e-05
MAFD1 [NCBI] 1.32385e-05
CSF2 [NCBI] 1.3106e-05
schwannomatosis [NCBI] 1.29674e-05
alzheimer disease, susceptibility to, mitochondrial [NCBI] 1.29674e-05
LISX1 [NCBI] 1.29674e-05
PKD3 [NCBI] 1.29674e-05
LGMD2E [NCBI] 1.29674e-05
NYS1 [NCBI] 1.29674e-05
TBX22 [NCBI] 1.29557e-05
XRCC3 [NCBI] 1.29557e-05
DYX1C1 [NCBI] 1.29557e-05
SNAI1 [NCBI] 1.29557e-05
NHLRC1 [NCBI] 1.29557e-05
SORL1 [NCBI] 1.29557e-05
CHD7 [NCBI] 1.29557e-05
XPNPEP2 [NCBI] 1.29557e-05
CCL7 [NCBI] 1.29557e-05
chromosome 17q21.31 microdeletion syndrome [NCBI] 1.29557e-05
FBLN5 [NCBI] 1.29557e-05
IL23R [NCBI] 1.29557e-05
CSPG4 [NCBI] 1.29557e-05
FABP4 [NCBI] 1.29557e-05
INS [NCBI] 1.28931e-05
ABCA4 [NCBI] 1.28659e-05
PTHLH [NCBI] 1.28547e-05
LPA [NCBI] 1.26321e-05
IDE [NCBI] 1.24152e-05
OPMD [NCBI] 1.23926e-05
GALR2 [NCBI] 1.21427e-05
NIPBL [NCBI] 1.21427e-05
FKBP1B [NCBI] 1.21427e-05
CYP4A11 [NCBI] 1.21427e-05
SLC22A4 [NCBI] 1.21427e-05
NRG1 [NCBI] 1.1526e-05
SCA14 [NCBI] 1.14804e-05
3-@methylcrotonyl-coa carboxylase 1 deficiency [NCBI] 1.14804e-05
HTX1 [NCBI] 1.14804e-05
scheie syndrome [NCBI] 1.14804e-05
GCKR [NCBI] 1.1437e-05
CITED2 [NCBI] 1.1437e-05
CCKBR [NCBI] 1.1437e-05
UNC119 [NCBI] 1.1437e-05
hemojuvelin [NCBI] 1.1437e-05
CYP3A7 [NCBI] 1.1437e-05
BDKRB2 [NCBI] 1.1437e-05
ACTN3 [NCBI] 1.1437e-05
OPHN1 [NCBI] 1.1437e-05
CASQ2 [NCBI] 1.1437e-05
CCL3L1 [NCBI] 1.1437e-05
AHI1 [NCBI] 1.1437e-05
NRG2 [NCBI] 1.1437e-05
FRZB [NCBI] 1.1437e-05
PRF1 [NCBI] 1.135e-05
RP2 [NCBI] 1.11542e-05
SCA1 [NCBI] 1.11415e-05
CMD1A [NCBI] 1.10824e-05
myoclonic dystonia [NCBI] 1.10824e-05
SPP1 [NCBI] 1.10342e-05
AIS [NCBI] 1.10073e-05
APS1 [NCBI] 1.09436e-05
BBS4 [NCBI] 1.08145e-05
RP1 [NCBI] 1.08145e-05
HTRA1 [NCBI] 1.08145e-05
ZFPM2 [NCBI] 1.08145e-05
ELOVL4 [NCBI] 1.08145e-05
GUCA1A [NCBI] 1.08145e-05
CCL11 [NCBI] 1.08145e-05
SLC22A18 [NCBI] 1.08145e-05
APOA5 [NCBI] 1.08145e-05
ALMS1 [NCBI] 1.08145e-05
VCL [NCBI] 1.08145e-05
SCNN1G [NCBI] 1.08145e-05
NIDDM [NCBI] 1.07624e-05
AFP [NCBI] 1.07563e-05
fabry disease [NCBI] 1.0547e-05
WHS [NCBI] 1.05292e-05
CADASIL [NCBI] 1.04056e-05
INSIG1 [NCBI] 1.02584e-05
PRKAA2 [NCBI] 1.02584e-05
LAMC1 [NCBI] 1.02584e-05
RGS4 [NCBI] 1.02584e-05
NPHP1 [NCBI] 1.02584e-05
HK2 [NCBI] 1.02584e-05
GATA2 [NCBI] 1.02584e-05
PEX1 [NCBI] 1.02584e-05
CLDN3 [NCBI] 1.02584e-05
INPPL1 [NCBI] 1.02584e-05
CCL4 [NCBI] 1.02584e-05
CCL5 [NCBI] 1.02584e-05
MYH7 [NCBI] 1.02405e-05
plasminogen deficiency, type i [NCBI] 1.01763e-05
methylmalonic aciduria and homocystinuria, cblc type [NCBI] 1.01763e-05
PI [NCBI] 9.89646e-06
malaria, susceptibility to [NCBI] 9.76345e-06
ZIC3 [NCBI] 9.75669e-06
SOST [NCBI] 9.75669e-06
CILP [NCBI] 9.75669e-06
MCM6 [NCBI] 9.75669e-06
GABBR2 [NCBI] 9.75669e-06
NLRP3 [NCBI] 9.75669e-06
SOAT1 [NCBI] 9.75669e-06
CX3CR1 [NCBI] 9.75669e-06
FUT3 [NCBI] 9.75669e-06
FLCN [NCBI] 9.75669e-06
ACP5 [NCBI] 9.6808e-06
HGF [NCBI] 9.56615e-06
MMP9 [NCBI] 9.42215e-06
MATN3 [NCBI] 9.30021e-06
FCGR2B [NCBI] 9.30021e-06
KRT18 [NCBI] 9.30021e-06
SFRP4 [NCBI] 9.30021e-06
CD209 [NCBI] 9.30021e-06
KIR3DL1 [NCBI] 9.30021e-06
EKD1 [NCBI] 9.21602e-06
LFS1 [NCBI] 9.15407e-06
RET [NCBI] 9.06753e-06
BDNF [NCBI] 9.05156e-06
NM [NCBI] 9.02465e-06
pearson marrow-pancreas syndrome [NCBI] 9.02465e-06
synovitis, granulomatous, with uveitis and cranial neuropathies [NCBI] 9.02465e-06
cutis laxa, autosomal recessive, type i [NCBI] 9.02465e-06
XFS [NCBI] 9.02465e-06
OPPG [NCBI] 9.02465e-06
d-bifunctional protein deficiency [NCBI] 9.02465e-06
hla-d histocompatibility type [NCBI] 9.02413e-06
SLPI [NCBI] 8.97418e-06
alsin [NCBI] 8.88199e-06
MTP [NCBI] 8.88199e-06
MED12 [NCBI] 8.88199e-06
GARS [NCBI] 8.88199e-06
ATP1A1 [NCBI] 8.88199e-06
AQP7 [NCBI] 8.88199e-06
TPH2 [NCBI] 8.88199e-06
CALCR [NCBI] 8.88199e-06
SFTPC [NCBI] 8.88199e-06
NQO1 [NCBI] 8.88199e-06
ICOSLG [NCBI] 8.88199e-06
UGT1A1 [NCBI] 8.82581e-06
CVID [NCBI] 8.81754e-06
MUC1 [NCBI] 8.817e-06
JAK2 [NCBI] 8.58961e-06
FOLR1 [NCBI] 8.49655e-06
CCL3 [NCBI] 8.49655e-06
TNNI3 [NCBI] 8.49655e-06
PLA2G7 [NCBI] 8.49655e-06
CCL18 [NCBI] 8.49655e-06
S100A8 [NCBI] 8.49655e-06
PCSK9 [NCBI] 8.49655e-06
CLEC4M [NCBI] 8.49655e-06
FSHB [NCBI] 8.49655e-06
CSF3R [NCBI] 8.49655e-06
HABP2 [NCBI] 8.49655e-06
GPT [NCBI] 8.40849e-06
FMF [NCBI] 8.22109e-06
CCL2 [NCBI] 8.14328e-06
RAB27A [NCBI] 8.13951e-06
GDAP1 [NCBI] 8.13951e-06
NTRK3 [NCBI] 8.13951e-06
PDCD1 [NCBI] 8.13951e-06
DTNBP1 [NCBI] 8.13951e-06
SDHB [NCBI] 8.13951e-06
LQT3 [NCBI] 8.00182e-06
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 [NCBI] 8.00182e-06
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive [NCBI] 8.00182e-06
AGS1 [NCBI] 8.00182e-06
BHD [NCBI] 8.00182e-06
ARMD4 [NCBI] 8.00182e-06
SCZD9 [NCBI] 8.00182e-06
NFNS [NCBI] 8.00182e-06
PNDM [NCBI] 8.00182e-06
TS [NCBI] 7.88945e-06
SGCA [NCBI] 7.80731e-06
PNPLA2 [NCBI] 7.80731e-06
FLG [NCBI] 7.80731e-06
CYP2C9 [NCBI] 7.80731e-06
LOX [NCBI] 7.64149e-06
MECP2 [NCBI] 7.52729e-06
SLC6A4 [NCBI] 7.50288e-06
ANGPTL4 [NCBI] 7.49703e-06
SCNN1A [NCBI] 7.49703e-06
CCR2 [NCBI] 7.49703e-06
CRX [NCBI] 7.49703e-06
GNB3 [NCBI] 7.49703e-06
WNT1 [NCBI] 7.49703e-06
GCG [NCBI] 7.49703e-06
CYP11A1 [NCBI] 7.49703e-06
POMC [NCBI] 7.48387e-06
CYP1A1 [NCBI] 7.42232e-06
VEGF [NCBI] 7.3184e-06
EPO [NCBI] 7.29586e-06
PMD [NCBI] 7.2315e-06
EIG [NCBI] 7.2315e-06
BHMT [NCBI] 7.20622e-06
PAPPA [NCBI] 7.20622e-06
IL6R [NCBI] 7.20622e-06
ANGPT2 [NCBI] 7.20622e-06
NCOA1 [NCBI] 7.20622e-06
GLDC [NCBI] 7.20622e-06
ACTA1 [NCBI] 7.20622e-06
CTHM [NCBI] 7.08938e-06
JH [NCBI] 7.08938e-06
PALS [NCBI] 7.08938e-06
succinic semialdehyde dehydrogenase deficiency [NCBI] 7.08938e-06
CTGF [NCBI] 7.08125e-06
wilson disease [NCBI] 7.06878e-06
IL6 [NCBI] 7.00006e-06
LMX1B [NCBI] 6.93283e-06
NR4A2 [NCBI] 6.93283e-06
GUCY2D [NCBI] 6.93283e-06
FOXL2 [NCBI] 6.93283e-06
PCDH15 [NCBI] 6.93283e-06
KCNE1 [NCBI] 6.93283e-06
ADRB3 [NCBI] 6.93283e-06
PRKCG [NCBI] 6.93283e-06
ECM1 [NCBI] 6.93283e-06
CASR [NCBI] 6.78496e-06
PPARA [NCBI] 6.75344e-06
MTR [NCBI] 6.73889e-06
ARNT [NCBI] 6.73889e-06
PHOX2B [NCBI] 6.67512e-06
NCSTN [NCBI] 6.67512e-06
DLL4 [NCBI] 6.67512e-06
HSD11B1 [NCBI] 6.67512e-06
factor v deficiency [NCBI] 6.63453e-06
adrenoleukodystrophy, autosomal neonatal form [NCBI] 6.54037e-06
LS [NCBI] 6.53222e-06
MTHFR [NCBI] 6.53188e-06
DCX [NCBI] 6.43159e-06
HIP1 [NCBI] 6.43159e-06
HLA-G [NCBI] 6.43159e-06
SDS [NCBI] 6.28077e-06
PARK6 [NCBI] 6.27259e-06
GCE [NCBI] 6.27259e-06
TTP [NCBI] 6.27259e-06
HSAN2 [NCBI] 6.27259e-06
hurler-scheie syndrome [NCBI] 6.27259e-06
SELP [NCBI] 6.20095e-06
AMPD1 [NCBI] 6.20095e-06
PDGFRA [NCBI] 6.20095e-06
IL1RN [NCBI] 6.20095e-06
ATP2A2 [NCBI] 6.20095e-06
RTS [NCBI] 6.09436e-06
UCP3 [NCBI] 6.04321e-06
ANXA5 [NCBI] 5.98208e-06
LCK [NCBI] 5.98208e-06
RPE65 [NCBI] 5.98208e-06
SDHD [NCBI] 5.98208e-06
NR3C2 [NCBI] 5.98208e-06
breast cancer [NCBI] 5.95378e-06
HLA-A [NCBI] 5.85851e-06
HSR [NCBI] 5.774e-06
MTND3 [NCBI] 5.774e-06
PMM2 [NCBI] 5.774e-06
ACOX1 [NCBI] 5.774e-06
EDA [NCBI] 5.774e-06
TFPI [NCBI] 5.59145e-06
LRP5 [NCBI] 5.57584e-06
HK1 [NCBI] 5.57584e-06
GSK3B [NCBI] 5.57584e-06
SPCH1 [NCBI] 5.53945e-06
neuropathy, congenital hypomyelinating [NCBI] 5.53945e-06
GCK [NCBI] 5.50611e-06
SMA1 [NCBI] 5.49889e-06
homocystinuria [NCBI] 5.42138e-06
SLN [NCBI] 5.38685e-06
BMP15 [NCBI] 5.38685e-06
CDKN1C [NCBI] 5.38685e-06
ALGS1 [NCBI] 5.26951e-06
CCD [NCBI] 5.24937e-06
CD44 [NCBI] 5.20633e-06
SLC22A5 [NCBI] 5.20633e-06
CTSK [NCBI] 5.20633e-06
TSG101 [NCBI] 5.20633e-06
OPA1 [NCBI] 5.20633e-06
IL4R [NCBI] 5.20633e-06
PTPN1 [NCBI] 5.20633e-06
AICDA [NCBI] 5.03369e-06
PRKAR1A [NCBI] 5.03369e-06
KL [NCBI] 5.03369e-06
AIRE [NCBI] 5.01658e-06
GJB2 [NCBI] 4.99321e-06
thyroid carcinoma, papillary [NCBI] 4.88866e-06
leopard syndrome 1 [NCBI] 4.88011e-06
FHM2 [NCBI] 4.88011e-06
SCN1 [NCBI] 4.88011e-06
NOG [NCBI] 4.86838e-06
CALCA [NCBI] 4.86838e-06
PRSS1 [NCBI] 4.86838e-06
LMNA [NCBI] 4.863e-06
MODY [NCBI] 4.84504e-06
KRT20 [NCBI] 4.7879e-06
LAM [NCBI] 4.776e-06
SCA2 [NCBI] 4.76159e-06
NS1 [NCBI] 4.76035e-06
RYR2 [NCBI] 4.70991e-06
PTX3 [NCBI] 4.70991e-06
PBP [NCBI] 4.70991e-06
PROS1 [NCBI] 4.70991e-06
DISC1 [NCBI] 4.70991e-06
IRS2 [NCBI] 4.55785e-06
RBP4 [NCBI] 4.55785e-06
TGFBR2 [NCBI] 4.55785e-06
alopecia, androgenetic [NCBI] 4.52353e-06
CPB2 [NCBI] 4.49831e-06
PG [NCBI] 4.42852e-06
IGF1R [NCBI] 4.41178e-06
CAPN3 [NCBI] 4.41178e-06
ALPL [NCBI] 4.41178e-06
IL18 [NCBI] 4.41178e-06
SLC40A1 [NCBI] 4.41178e-06
MTRNR1 [NCBI] 4.41178e-06
PGR [NCBI] 4.32628e-06
EGFR [NCBI] 4.31555e-06
RNASE3 [NCBI] 4.31351e-06
PCLD [NCBI] 4.28635e-06
CBAVD [NCBI] 4.28635e-06
KAL2 [NCBI] 4.28635e-06
BFLS [NCBI] 4.28635e-06
IL12B [NCBI] 4.27136e-06
CXCL12 [NCBI] 4.27136e-06
FASN [NCBI] 4.27136e-06
hypertrophic neuropathy of dejerine-sottas [NCBI] 4.18553e-06
glioma of brain, familial [NCBI] 4.18553e-06
TNF [NCBI] 4.1632e-06
DNMT3B [NCBI] 4.13623e-06
PAFAH1B1 [NCBI] 4.13623e-06
FBN1 [NCBI] 4.0942e-06
MAOA [NCBI] 4.0942e-06
IKBKG [NCBI] 4.00611e-06
complement component 2 deficiency [NCBI] 4.00611e-06
SPG4 [NCBI] 4.00611e-06
COMP [NCBI] 3.96386e-06
GDF5 [NCBI] 3.88071e-06
GHRL [NCBI] 3.88071e-06
EPHX1 [NCBI] 3.88071e-06
OA1 [NCBI] 3.88071e-06
sickle cell anemia [NCBI] 3.8616e-06
ALS1 [NCBI] 3.83406e-06
DFSP [NCBI] 3.77832e-06
NTRK2 [NCBI] 3.75978e-06
PTHR1 [NCBI] 3.75978e-06
BCL6 [NCBI] 3.75978e-06
MYO7A [NCBI] 3.75978e-06
PARK8 [NCBI] 3.75127e-06
SCA10 [NCBI] 3.75127e-06
autonomic control, congenital failure of [NCBI] 3.75127e-06
canavan disease [NCBI] 3.75127e-06
refsum disease, infantile form [NCBI] 3.75127e-06
KTCN1 [NCBI] 3.75127e-06
ESR1 [NCBI] 3.72309e-06
GK [NCBI] 3.64309e-06
ESR2 [NCBI] 3.64309e-06
RAG1 [NCBI] 3.64309e-06
LTA [NCBI] 3.64309e-06
SLC26A4 [NCBI] 3.64309e-06
glycogen storage disease ii [NCBI] 3.61288e-06
LRP1 [NCBI] 3.55731e-06
CHEK2 [NCBI] 3.53041e-06
PTPRC [NCBI] 3.53041e-06
OPTN [NCBI] 3.53041e-06
PDE6B [NCBI] 3.53041e-06
SHOX [NCBI] 3.53041e-06
GIP [NCBI] 3.47117e-06
ATF2 [NCBI] 3.42154e-06
MAPT [NCBI] 3.38178e-06
DES [NCBI] 3.31631e-06
ATP7B [NCBI] 3.31631e-06
FY [NCBI] 3.31631e-06
GRN [NCBI] 3.31631e-06
STAT3 [NCBI] 3.30445e-06
CGL2 [NCBI] 3.269e-06
protoporphyria, erythropoietic [NCBI] 3.21453e-06
GAA [NCBI] 3.21453e-06
H19 [NCBI] 3.21453e-06
LDLR [NCBI] 3.2084e-06
MMP3 [NCBI] 3.11604e-06
ADIPOQ [NCBI] 3.0207e-06
ARPKD [NCBI] 2.9915e-06
velocardiofacial syndrome [NCBI] 2.97714e-06
POLG [NCBI] 2.92837e-06
ENG [NCBI] 2.92837e-06
USF1 [NCBI] 2.92837e-06
PYY [NCBI] 2.89817e-06
KAL1 [NCBI] 2.83891e-06
C4A [NCBI] 2.83891e-06
aortic aneurysm, abdominal [NCBI] 2.83448e-06
cardiofaciocutaneous syndrome [NCBI] 2.83448e-06
pulmonary fibrosis, idiopathic [NCBI] 2.83448e-06
ulcerative colitis, susceptibility to [NCBI] 2.83448e-06
hepatitis c virus, susceptibility to [NCBI] 2.83448e-06
MTATP6 [NCBI] 2.7522e-06
ABCA1 [NCBI] 2.66814e-06
APCS [NCBI] 2.66814e-06
CREBBP [NCBI] 2.66814e-06
IFNG [NCBI] 2.66814e-06
amyloidosis vi [NCBI] 2.6668e-06
TLR5 [NCBI] 2.5866e-06
TPO [NCBI] 2.58473e-06
porphyria variegata [NCBI] 2.57795e-06
CHH [NCBI] 2.57795e-06
gaucher disease, type i [NCBI] 2.57795e-06
RTT [NCBI] 2.56385e-06
FGF23 [NCBI] 2.50749e-06
PSNP1 [NCBI] 2.44339e-06
UCP1 [NCBI] 2.4263e-06
DAO [NCBI] 2.35618e-06
SH2D1A [NCBI] 2.35618e-06
FTD [NCBI] 2.33523e-06
CFB [NCBI] 2.28381e-06
MTND1 [NCBI] 2.28381e-06
FH [NCBI] 2.28381e-06
IP [NCBI] 2.27526e-06
HMBS [NCBI] 2.22501e-06
GALT [NCBI] 2.21352e-06
UNG [NCBI] 2.21352e-06
RLBP1 [NCBI] 2.21352e-06
AGT [NCBI] 2.21352e-06
ABL1 [NCBI] 2.14523e-06
CRMO [NCBI] 2.09194e-06
biotinidase deficiency [NCBI] 2.09194e-06
acyl-coa dehydrogenase, medium-chain, deficiency of [NCBI] 2.09194e-06
glycogen storage disease v [NCBI] 2.09194e-06
EFE [NCBI] 2.09194e-06
hyperglycerolemia [NCBI] 2.09194e-06
andersen cardiodysrhythmic periodic paralysis [NCBI] 2.09194e-06
PTEN [NCBI] 2.03679e-06
TCOF [NCBI] 2.01942e-06
A2M [NCBI] 2.01438e-06
PLP1 [NCBI] 2.01438e-06
NAT1 [NCBI] 1.95169e-06
F2 [NCBI] 1.95169e-06
PSEN2 [NCBI] 1.95169e-06
CEL [NCBI] 1.89073e-06
CMH [NCBI] 1.86506e-06
HOS [NCBI] 1.84471e-06
LQT1 [NCBI] 1.84271e-06
MCP [NCBI] 1.827e-06
GHR [NCBI] 1.82209e-06
NEM3 [NCBI] 1.77682e-06
PBD [NCBI] 1.77682e-06
CPX [NCBI] 1.77682e-06
OCRL [NCBI] 1.77682e-06
charge syndrome [NCBI] 1.77682e-06
central core disease of muscle [NCBI] 1.77682e-06
IGF1 [NCBI] 1.77381e-06
ATF3 [NCBI] 1.77381e-06
KCNQ1 [NCBI] 1.77381e-06
NR1I2 [NCBI] 1.73449e-06
PLTP [NCBI] 1.72831e-06
NOS3 [NCBI] 1.71774e-06
PKD2 [NCBI] 1.71774e-06
FGFR2 [NCBI] 1.69629e-06
MKS1 [NCBI] 1.67607e-06
TYMS [NCBI] 1.67188e-06
NF2 [NCBI] 1.66319e-06
ITGB3 [NCBI] 1.66319e-06
PNMT [NCBI] 1.63708e-06
MAP2 [NCBI] 1.61781e-06
MPO [NCBI] 1.61364e-06
MMP2 [NCBI] 1.61012e-06
PSEN1 [NCBI] 1.60282e-06
IRS1 [NCBI] 1.55847e-06
BPES [NCBI] 1.51372e-06
BIRC1 [NCBI] 1.50822e-06
TP53 [NCBI] 1.50373e-06
pheochromocytoma [NCBI] 1.49513e-06
ALMS [NCBI] 1.49513e-06
apc gene [NCBI] 1.4553e-06
PF4 [NCBI] 1.42968e-06
CCL17 [NCBI] 1.4117e-06
ADM [NCBI] 1.39236e-06
CDK2 [NCBI] 1.37407e-06
IAPP [NCBI] 1.37407e-06
NPC1 [NCBI] 1.35788e-06
BWS [NCBI] 1.35146e-06
ADA [NCBI] 1.34844e-06
APOD [NCBI] 1.32026e-06
THPO [NCBI] 1.32026e-06
ANG [NCBI] 1.27636e-06
ALPS [NCBI] 1.25814e-06
DFNB1 [NCBI] 1.24429e-06
CEACAM5 [NCBI] 1.21357e-06
VWS [NCBI] 1.20879e-06
hurler syndrome [NCBI] 1.20879e-06
CFTR [NCBI] 1.10165e-06
MLH1 [NCBI] 1.03629e-06
DBA [NCBI] 1.03056e-06
myoclonic epilepsy of lafora [NCBI] 1.02202e-06
SPDA1 [NCBI] 1.02202e-06
DAR [NCBI] 1.02202e-06
RYR1 [NCBI] 9.99906e-07
BMP2 [NCBI] 9.64487e-07
UGB [NCBI] 9.64487e-07
MFS [NCBI] 9.58723e-07
bullous erythroderma ichthyosiformis congenita of brocq [NCBI] 9.31914e-07
IDUA [NCBI] 8.96451e-07
SNCA [NCBI] 8.96451e-07
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 8.95418e-07
G6PD [NCBI] 8.92668e-07
SOD2 [NCBI] 8.48559e-07
STC1 [NCBI] 8.31999e-07
mycobacterium tuberculosis, susceptibility to [NCBI] 8.26272e-07
leiomyomatosis and renal cell cancer, hereditary [NCBI] 8.26272e-07
ADHD [NCBI] 8.24471e-07
leber optic atrophy [NCBI] 8.06496e-07
SCA7 [NCBI] 8.04677e-07
STAT6 [NCBI] 8.01064e-07
VHL [NCBI] 7.13182e-07
PLN [NCBI] 7.13182e-07
F3 [NCBI] 7.09143e-07
CNTF [NCBI] 6.85836e-07
LCT [NCBI] 6.85468e-07
HHF2 [NCBI] 6.85305e-07
MHS1 [NCBI] 6.85305e-07
OCP [NCBI] 6.85305e-07
CD [NCBI] 6.68938e-07
CDLS1 [NCBI] 6.68938e-07
hypophosphatasia, infantile [NCBI] 6.55222e-07
STL1 [NCBI] 6.55222e-07
RP3 [NCBI] 6.55222e-07
SCZD [NCBI] 6.43713e-07
TLR2 [NCBI] 6.42877e-07
LAT [NCBI] 6.323e-07
PRNP [NCBI] 5.88618e-07
TNFRSF1A [NCBI] 5.8204e-07
HHT [NCBI] 5.7412e-07
down syndrome [NCBI] 5.7412e-07
KCNH2 [NCBI] 5.60988e-07
SMN1 [NCBI] 5.57961e-07
COL2A1 [NCBI] 5.57961e-07
CMT1A [NCBI] 5.4938e-07
FMR1 [NCBI] 5.47752e-07
MEN1 [NCBI] 5.11831e-07
FPLD2 [NCBI] 5.07222e-07
LGMD2C [NCBI] 5.07222e-07
exostoses, multiple, type i [NCBI] 5.07222e-07
galactosemia [NCBI] 4.71463e-07
BRRS [NCBI] 4.71463e-07
LEPR [NCBI] 4.27296e-07
FAAH [NCBI] 4.10337e-07
PTGS2 [NCBI] 3.88686e-07
phenylketonuria [NCBI] 3.80878e-07
SGBS1 [NCBI] 3.80782e-07
gastric cancer [NCBI] 3.80782e-07
NPS [NCBI] 3.77695e-07
CMT1B [NCBI] 3.77695e-07
hypertension, essential [NCBI] 3.74826e-07
IL4 [NCBI] 3.70254e-07
ZS [NCBI] 3.69755e-07
ALK [NCBI] 3.64279e-07
DMD [NCBI] 3.53108e-07
TYR [NCBI] 3.35077e-07
PLG [NCBI] 3.34401e-07
GNAS [NCBI] 3.0208e-07
PMP22 [NCBI] 2.99371e-07
HSCR1 [NCBI] 2.99295e-07
AR [NCBI] 2.8529e-07
costello syndrome [NCBI] 2.74557e-07
LGMD2A [NCBI] 2.74557e-07
CVS [NCBI] 2.74557e-07
PGL1 [NCBI] 2.74557e-07
MC1R [NCBI] 2.71183e-07
RB1 [NCBI] 2.61442e-07
MYOC [NCBI] 2.56497e-07
DYT1 [NCBI] 2.184e-07
SCS [NCBI] 2.184e-07
IFNA1 [NCBI] 2.02631e-07
PCI [NCBI] 2.02631e-07
CML [NCBI] 1.8732e-07
immunodeficiency-centromeric instability-facial anomalies syndrome [NCBI] 1.8732e-07
SPG4 [NCBI] 1.8732e-07
HCH [NCBI] 1.8732e-07
COL1A1 [NCBI] 1.4564e-07
SRS [NCBI] 1.28665e-07
IDDM [NCBI] 1.28665e-07
ATM [NCBI] 1.07725e-07
SERPINA6 [NCBI] 1.01155e-07
TPMT [NCBI] 9.92547e-08
FGFR3 [NCBI] 8.48596e-08
SPINK1 [NCBI] 7.616e-08
hemophilia a [NCBI] 7.1998e-08
CCND1 [NCBI] 6.92136e-08
WFS1 [NCBI] 6.54394e-08
von willebrand disease [NCBI] 5.64138e-08
IGFALS [NCBI] 5.0549e-08
HFM [NCBI] 2.99487e-08
lactase persistence [NCBI] 2.88384e-08
FGFR1 [NCBI] 2.63641e-08
IGER [NCBI] 2.53507e-08
RSTS [NCBI] 2.53507e-08
TERT [NCBI] 1.95291e-08
TNC [NCBI] 1.89942e-08
SLC2A4 [NCBI] 1.65767e-08
LEP [NCBI] 1.65767e-08
SLC6A3 [NCBI] 7.66404e-09
PDS [NCBI] 7.29129e-09
aHUS [NCBI] 7.29129e-09
LKS [NCBI] 6.25126e-09
SMEI [NCBI] 6.25126e-09
TTR [NCBI] 3.83995e-09
AHR [NCBI] 3.42615e-09
BGLAP [NCBI] 2.18899e-11
AGER [NCBI] 2.18899e-11
growth hormone insensitivity syndrome [NCBI] 6.00398e-12
HHF1 [NCBI] 6.00398e-12



Database Center for Life Science